Carvedilol Tablet, Film Coated
Product Images NDC 82804-191

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 82804-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-191-60 (Image 01)

Label for Carvedilol 3.125 mg tablets, film-coated, elliptical-shaped with debossing on both sides. Pack of 60 tablets manufactured in India for Teva Pharmaceuticals USA by Proficient Rx LP, North Wales, PA. Storage instructions and multiple barcode elements are visible.*

FDA Label Image

Structural Formula For Carvedilol (Image 1)

Chemical structure of Carvedilol, showing its molecular framework with various functional groups including indole and methoxyphenyl moieties, consistent with the active ingredient Carvedilol in this drug product.*

FDA Label Image

Fig 1 (Image 2)

A line graph depicting percent mortality over months for two groups: Carvedilol and Placebo. The X-axis represents time in months (0 to 21), and the Y-axis shows percent mortality (0 to 30%). The Carvedilol group shows lower mortality compared to Placebo. A p-value of 0.0014 is noted on the graph.*

FDA Label Image

Fig 2 (Image 3)

A forest plot displaying hazard ratios for various subgroups including men, women, age groups, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. Each subgroup is represented by a point estimate with confidence intervals along a horizontal axis labeled from 0.0 to 2.0, indicating the hazard ratio values.*

FDA Label Image

Fig 3 (Image 4)

A line chart showing % mortality over a 24-month period comparing Carvedilol and placebo groups. The y-axis represents % mortality and the x-axis represents months. The chart includes a p-value of 0.03, indicating statistical comparison between groups.*

FDA Label Image

Fig 4 (Image 5)

A forest plot showing hazard ratios for various subgroups of patients, including age, sex, timing post-myocardial infarction (MI), prior treatments, cardiac conditions, and comorbidities such as hypertension and diabetes. The x-axis represents hazard ratios ranging from 0.4 to 1.3, with data points and confidence intervals depicted for each subgroup comparison.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.